Stem cell infusion for kidney disease from diabetes
This study tests if a single infusion of stem cells from umbilical cord blood can slow kidney damage caused by type 2 diabetes. It may help preserve kidney function and reduce protein in the urine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 2 diabetes and have been on stable diabetes and blood pressure medications for at least 3 months.
- Your kidney function is moderately reduced (eGFR between 30 and 90) and you have protein in your urine.
- You have had a kidney biopsy showing that your kidney damage is due to diabetes.
- You are not on dialysis and have not used stem cell treatments before.
- You do not have other serious health conditions (like heart disease, stroke, infections, or cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests whether a type of stem cell therapy can help people with chronic kidney disease caused by diabetes or high blood pressure. It aims to see if the treatment is safe and can slow kidney damage.
This trial tests whether a type of stem cell called mesenchymal stromal cells (Amimestrocel) can help people with diabetic kidney disease. It aims to see if the treatment is safe and can improve kidney function.
Hear when a new Diabetic Nephropathy Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.